View More View Less
  • 1 Istanbul University Biology Department, Science Faculty Istanbul Turkey
  • | 2 Istanbul Kültür University Faculty of Science and Letters Istanbul Turkey
Restricted access

In this study the antiproliferative effects of Paclitaxel (PAC), Epirubicin (EPI) and Tamoxifen (TAM) on growth kinetics of Ehrlich Ascites Tumor (EAT) cells were examined in culture. An estrogen-receptor-positive ER (+) hyperdiploid EAT cell line growing in vitro was also analysed in the present study. IC 50 doses of PAC, EPI and TAM (12 μg/ml, 12 μg/ml and 2μg/ml, respectively) were used. Cells were treated with the above doses for 0, 4, 8, 16, 24 and 32 hrs. At the end of these periods, living cell numbers were determined by collecting EAT cells in every group for growth study rate and for MTT assay. Therefore, the mitotic index was determined in the same experimental groups. The Proliferation of EAT cells, inhibited by PAC, EPI and TAM concentrations was compared to control with increasing treatment time (4–32 hrs). Treatment of PAC, EPI and TAM alone for 24 hrs decreased the proliferation rate of EAT cells by 50% with respect to control. The inhibition of proliferation rate was higher in double drug treatment than that in single drug treatment with increased treatment time. In the treatment of three drugs applied for 32 hrs, this effect reached a maximum and proliferation rate decreased by 12% as compared to the (100%) control. In our studies, when the mitotic index parameter data were evaluated to determine which phase of the cell cycle was affected by PAC to cause the repression of cell reproduction, it was found that PAC exerted of its cytotoxic effect by causing cell accumulation at mitosis. The accumulation of the cells resulted in an increase in mitotic index values, which was an expected consequence of PAC treatment. It was observed that depending on the drug treatments, inhibition of proliferation rate and mitotic index in EAT cells were increased with respect to control, being with statistically significant occurrence (p < 0.01–p < 0.001). As a result, concomitant treatment combined with hormonal therapy has given improved results compared with single treatment and PAC + EPI + TAM treatments had a maximum synergistic effect for 32 hrs (p < 0.001).

  • Aydıner, A., Rıdvanoğulları, M., Anıl, D., Topuz, E., Nurten, R., Disci, R. (1997) Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells. J. Cancer Res. Clin. Oncol. 123 , 113–117.

    Disci R. , 'Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells ' (1997 ) 123 J. Cancer Res. Clin. Oncol. : 113 -117.

    • Search Google Scholar
  • Clarke, R. B., Laidlaw, I. J., Jones, L. J., Howell, A., Anderson, E. (1993) Effect of tamoxifen on Ki67 labelling index in human breast tumors and its relationship to estrogen progesterone receptor status. Br. J. Cancer 67 , 606–611.

    Anderson E. , 'Effect of tamoxifen on Ki67 labelling index in human breast tumors and its relationship to estrogen progesterone receptor status ' (1993 ) 67 Br. J. Cancer : 606 -611.

    • Search Google Scholar
  • Cuzick, J., Baum, M. (1985) Tamoxifen and contralateral breast cancer. Lancet 2 (8449), 282.

    Baum M. , 'Tamoxifen and contralateral breast cancer ' (1985 ) 2 Lancet : 282 -.

  • Gullino, P. M., Pettigrew, H. N., Grantham, F. H. (1975) N-Nitrosomethylurea as mammary gland carcinogen in rats. J. Nat. Cancer Inst. 54 , 401–414.

    Grantham F. H. , 'N-Nitrosomethylurea as mammary gland carcinogen in rats ' (1975 ) 54 J. Nat. Cancer Inst. : 401 -414.

    • Search Google Scholar
  • Hill, B. T., Whelan, R. D. H. (1982) A comparison of the lethal and Kinetics effects of doxorubicin and 4′-epidoxorubicin in vitro . Tumori 68 , 29–37.

    Whelan R. D. H. , 'A comparison of the lethal and Kinetics effects of doxorubicin and 4′-epidoxorubicin in vitro ' (1982 ) 68 Tumori : 29 -37.

    • Search Google Scholar
  • Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N. (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Nat. Cancer Inst. 83 , 1797–1805.

    Hortobagyi G. N. , 'Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer ' (1991 ) 83 J. Nat. Cancer Inst. : 1797 -1805.

    • Search Google Scholar
  • Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., Wilson L. (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56 , 816–825.

    Wilson L. , 'Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death ' (1996 ) 56 Cancer Res. : 816 -825.

    • Search Google Scholar
  • Kennedy, D. O., Kojima, A., Moffat, J., Yamagiwa, H., Yano, Y. (2002) Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin. Cancer Lett. 179 , 25–32.

    Yano Y. , 'Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin ' (2002 ) 179 Cancer Lett. : 25 -32.

    • Search Google Scholar
  • Klotz, I. M. (1982) Number of receptor sites from Scatchard graphs, facts and fantasies. Science 217 , 1247–1249.

    Klotz I. M. , 'Number of receptor sites from Scatchard graphs, facts and fantasies ' (1982 ) 217 Science : 1247 -1249.

    • Search Google Scholar
  • Lippman, M., Huff, K. A. (1976) A demonstration of androgen and estrogen in a human breast cancer using a new protamine sulfate assay. Cancer. 38 , 868–874.

    Huff K. A. , 'A demonstration of androgen and estrogen in a human breast cancer using a new protamine sulfate assay ' (1976 ) 38 Cancer. : 868 -874.

    • Search Google Scholar
  • Long, B. H., Fairchild, C. R. (1994) Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res. 54 , 4355–4361.

    Fairchild C. R. , 'Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase ' (1994 ) 54 Cancer Res. : 4355 -4361.

    • Search Google Scholar
  • Lu, K. H., Lue, K. H., Chou, M. C., Chung, J. G. (2005) Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 os). J. Orthopaedic Res. 23 , 988–994.

    Chung J. G. , 'Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 os) ' (2005 ) 23 J. Orthopaedic Res. : 988 -994.

    • Search Google Scholar
  • Mc Guire, W. L., Horwitz, K. B., Zava, D. T., Garola, R. E., Chamness, G. C. (1978) Hormones in breast cancer. Metabolism 27 , 487–501.

    Chamness G. C. , 'Hormones in breast cancer ' (1978 ) 27 Metabolism : 487 -501.

  • McGuire, W. L., Tandon, A. K., Allred, D. C., Chamness, G. C., Mc Clark, G. M. (1990) How to use prognostic factors in axillary node-negative breast cancer patients. J. Nat. Cancer Inst. 82 , 1006–1015.

    Mc Clark G. M. , 'How to use prognostic factors in axillary node-negative breast cancer patients ' (1990 ) 82 J. Nat. Cancer Inst. : 1006 -1015.

    • Search Google Scholar
  • Mondal, T. K., Bhatta, D. (2002) Superantigen-induced death of tumor cells is mediated by cytotoxic lymphocytes, cytokines, and nitric oxide. Biochem. Biophys. Res. Commun. 290 , 1336–1342.

    Bhatta D. , 'Superantigen-induced death of tumor cells is mediated by cytotoxic lymphocytes, cytokines, and nitric oxide ' (2002 ) 290 Biochem. Biophys. Res. Commun. : 1336 -1342.

    • Search Google Scholar
  • Mosmann, T. (1983) Rapid Colorimetric Assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65 , 55–63.

    Mosmann T. , 'Rapid Colorimetric Assay for cellular growth and survival: Application to proliferation and cytotoxicity assays ' (1983 ) 65 J. Immunol. Meth. : 55 -63.

    • Search Google Scholar
  • Norton, L., Seidman, A. (1992) Taxol plus recombinant human granulocyte colony stimulating factor as initial chemotherapy for metastatic breast cancer. 2nd Natl. Cancer Inst. Workshop on Taxol and Taxus, Alexandria VA., pp. 23–24.

  • Osborne, C. K. (1994) Interactions of tamoxifen with cytotoxic chemotherapy for breast cancer. Long term tamoxifen for breast cancer. In: Jordan, V. C. (ed.) Long Term Tamoxifen for Breast Cancer . Wisconsin University Press, Madison., pp. 181–198.

    Osborne C. K. , '', in Long Term Tamoxifen for Breast Cancer , (1994 ) -.

  • Osborne, C. K., Bold, D. H., Clark, G. M., Trent, J. M. (1983) Effect of tamoxifen on human breast cancer cell cycle kinetics. Accumulation of cells in early G1 phase. Cancer Res. 43 , 3583–3585.

    Trent J. M. , 'Effect of tamoxifen on human breast cancer cell cycle kinetics. Accumulation of cells in early G1 phase ' (1983 ) 43 Cancer Res. : 3583 -3585.

    • Search Google Scholar
  • Osborne, C. K., Kitten, L., Arteaga, C. L. (1989) Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens. J. Clin. Oncol. 7 , 710–717.

    Arteaga C. L. , 'Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens ' (1989 ) 7 J. Clin. Oncol. : 710 -717.

    • Search Google Scholar
  • Özcan Arıcan, G. (2005) Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index. Cancer Chemother. Pharmacol. 56 , 221–229.

    Özcan Arıcan G. , 'Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index ' (2005 ) 56 Cancer Chemother. Pharmacol. : 221 -229.

    • Search Google Scholar
  • Özcan Arıcan, G., Topçul, M. R. (2003) Effect of epirubicin on mitotic index in cultured L-cells. J. Cell and Molecular Biol. 2 , 43–48.

    Topçul M. R. , 'Effect of epirubicin on mitotic index in cultured L-cells ' (2003 ) 2 J. Cell and Molecular Biol. : 43 -48.

    • Search Google Scholar
  • Özcan, F. G., Topçul, M. R., Yılmazer, N., Rıdvanoğulları, M. (1997) Effect of epirubicin on 3 H-thymidine labelling index in cultured L-strain cells. J. Exp. Clin. Cancer Res. 16 , 23–27.

    Rıdvanoğulları M. , 'Effect of epirubicin on 3H-thymidine labelling index in cultured L-strain cells ' (1997 ) 16 J. Exp. Clin. Cancer Res. : 23 -27.

    • Search Google Scholar
  • Pigram, W. J., Fuller, W., Hamilton, L. D. (1972) Stereochemistry of interaction: Interaction of daunomycin with DNA. Nat. New Biol. 235 , 17–19.

    Hamilton L. D. , 'Stereochemistry of interaction: Interaction of daunomycin with DNA ' (1972 ) 235 Nat. New Biol. : 17 -19.

    • Search Google Scholar
  • Plosker, G. L., Faulds, D. (1993) Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 45 , 788–856.

    Faulds D. , 'Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy ' (1993 ) 45 Drugs : 788 -856.

    • Search Google Scholar
  • Raynaud, J. P., Martin, P. M., Bouton, M. M., Ojasoo, T. (1978) 11-beta-Methoxy-17-ethynyl-1,3,5(10)-estratrience-3,17-beta-diol, a tag for estrogen receptor binding sites in human tissues. Cancer Res. 38 , 3044–3050.

    Ojasoo T. , '11-beta-Methoxy-17-ethynyl-1,3,5(10)-estratrience-3,17-beta-diol, a tag for estrogen receptor binding sites in human tissues ' (1978 ) 38 Cancer Res. : 3044 -3050.

    • Search Google Scholar
  • Rowinsky, E. K., Onetto, N., Canetta, R. M., Arbuck, S. G. (1992) Taxol: The first of the taxanes, an important new class of antitumor agents. Semin. Oncol. 19 , 646–662.

    Arbuck S. G. , 'Taxol: The first of the taxanes, an important new class of antitumor agents ' (1992 ) 19 Semin. Oncol. : 646 -662.

    • Search Google Scholar
  • Schiff, P. B., Horwitz S. B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Cell Biol. 77 , 1561–1565.

    Horwitz S. B. , 'Taxol stabilizes microtubules in mouse fibroblast cells ' (1980 ) 77 Cell Biol. : 1561 -1565.

    • Search Google Scholar
  • Stewart, H. L., Snell, K. C., Dunham, L. J., Schleyen, S. M. (1959) V2 carcinoma, rabbit. In: Atlas of Tumor Pathology, Transplantable and Transmissible Tumors of Animals . Section XII, fascicle 40. AFIP, Washington D. C., pp. 38–42.

    Schleyen S. M. , '', in Atlas of Tumor Pathology, Transplantable and Transmissible Tumors of Animals , (1959 ) -.

  • Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., Liu, L. F. (1984) Adriamycin induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226 , 466–468.

    Liu L. F. , 'Adriamycin induced DNA damage mediated by mammalian DNA topoisomerase II ' (1984 ) 226 Science : 466 -468.

    • Search Google Scholar
  • Wang, T. H., Wang, H.-S., Soong, Y. K. (2000) Paclitaxel-induced cell death. Where the cell cycle and apoptosis come together. Cancer 88 , 2619–2628.

    Soong Y. K. , 'Paclitaxel-induced cell death. Where the cell cycle and apoptosis come together ' (2000 ) 88 Cancer : 2619 -2628.

    • Search Google Scholar
  • Zar, J. H. (1984) Biostatistical Analysis . 2nd Edition. Prentice-Hall Inc, Englewood Cliffs, New Jersey.

    Zar J. H. , '', in Biostatistical Analysis , (1984 ) -.